Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly

✍ Scribed by A. J. Varewijck; J. A. M. J. L. Janssen; M. Vähätalo; L. J. Hofland; S. W. J. Lamberts; H. Yki-Järvinen

• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 277 KB
• Volume: 55
• Category: Article
• ISSN: 0012-186X
• DOI: 10.1007/s00125-011-2435-7